The USS aims to streamline LVO screening by utilizing multiple validated stroke scales simultaneously.
We prospectively applied eight stroke screening scales (NIHSS, BE-FAST, VAN, LAMS, FAST-ED, EMS RACE, 3-ISS, and PASS) to 199 stroke activations between January 2021 and December 2023. In a prospective, external validation study, the scales were later recalculated using the USS with a modified NIHSS score that included hand grip strength. A Bland-Altman analysis was conducted to assess agreement between manual and USS-calculated scores.
PASS demonstrated the strongest agreement, with minimal bias (mean difference, M = -0.0402), a standard deviation (SD) of 0.315, and narrow Limits of Agreement (LoAs) (-0.657–0.576). BE-FAST and VAN also showed strong agreement, with minimal biases (M = -0.121 and M = -0.106), low SDs (0.369 and 0.367), and tight LoAs (-0.844–0.603 and -0.825–0.614). LAMS showed strong agreement with a small positive bias (M = 0.151), SD: 0.685, and LoAs: -1.19–1.49.
FAST-ED, 3-ISS, and EMS-RACE displayed moderate agreement. FAST-ED had a moderate bias (M = -0.151), SD: 0.991, and LoAs: -2.09–1.79, while 3-ISS had a moderate bias (M = -0.538), SD: 0.981, and LoAs: -2.47–1.39. EMS-RACE had a moderate bias (M = -0.387), SD: 1.43, and wider LoAs (-3.19–2.42).
NIHSS showed the weakest agreement, with the largest bias (M = -0.975), SD: 1.48, and LoAs: -3.87–1.92, reflecting expected discrepancies due to its modification.
The USS demonstrates strong to moderate agreement with manual methods across tested stroke scales, with minimal biases and consistent performances. With further refinement and larger studies, the USS could become a valuable tool to expedite LVO screening.